Comparison of Oral P2Y12 Inhibitors in Acute Coronary Syndrome

被引：0
|
作者：
Ferracane, Elisa [1 ]
Bartoli, Laura [1 ]
Trippoli, Sabrina [1 ]
Messori, Andrea [1 ]
机构：
[1] Reg Toscana, Via Alderotti 46-N, I-50139 Florence, Italy
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2020年 / 135卷
关键词：
D O I：
10.1016/j.amjcard.2020.08.023
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：183 / 184
页数：2
相关论文
共 50 条
  • [41] Comparison of Prescription and Bleeding Rates and Clinical Outcomes of Contemporary P2Y12 Inhibitors in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Choe, J. C.
    Cha, K. S.
    Lee, S. H.
    Kim, D. Y.
    Ahn, J.
    Park, J. S.
    Lee, H. W.
    Oh, J. H.
    Choi, J. H.
    Lee, H. C.
    Hong, T. J.
    Jeong, M. H.
    EUROPEAN HEART JOURNAL, 2017, 38 : 870 - 870
  • [42] Switching of Oral P2Y12 Inhibitor Treatment in Patients with Acute Coronary Syndrome: Prevalence, Predictors, and Prognosis
    Carrillo-Aleman, Luna
    Marin, Francisco
    Rivera-Caravaca, Jose M.
    Vicente-Ibarra, Nuria
    Candela-Sanchez, Elena
    Esteve-Pastor, Maria A.
    Lozano, Teresa
    Sandin-Rollan, Miriam
    Pernias-Escrig, Vicente
    Macias, Manuel
    Quintana-Giner, Miriam
    Veliz, Andrea
    Orenes-Pinero, Esteban
    Martinez-Martinez, Juan G.
    Ruiz-Nodar, Juan M.
    CLINICAL DRUG INVESTIGATION, 2019, 39 (03) : 275 - 283
  • [43] APPROACH OF WITHHOLDING P2Y12 INHIBITORS FOR URGENT CORONARY ARTERY BYPASS GRAFTING IN DIABETIC PATIENTS WITH ACUTE CORONARY SYNDROME
    Seikh, Ghulam Abbas
    Ahmed, Faisal
    Shah, Arshad Ali
    Asad, Syed Dilbahar Ali Shah
    Ashfaq, Fareheen
    Lashari, Muhammad Nawaz
    Lashari, Muhammad Nawaz
    PAKISTAN HEART JOURNAL, 2022, 55 (04): : 346 - 350
  • [44] COMPARATIVE SAFETY ASSESSMENT OF P2Y12 INHIBITORS FOR SECONDARY PROPHYLAXIS IN ACUTE CORONARY SYNDROME AFTER PERCUTANEOUS CORONARY INTERVENTION
    Kumar, A.
    Lutsey, P. L.
    St Peter, W. L.
    Schommer, J. C.
    Van't Hof, J. R.
    Rajpurohit, A.
    Farley, J. F.
    VALUE IN HEALTH, 2022, 25 (07) : S311 - S311
  • [45] Relative Efficacy and Safety of oral P2Y12 inhibitors in Acute coronary syndrome: An Updated Network Meta-Analysis of Randomized Trials
    Shah, Rahman
    Hwang, Inyong Hwang
    Nayyar, Mannu
    Slomka, Teresa
    Rashid, Abdul
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (18) : B41 - B42
  • [46] Meta-Analysis of Comparison of the Newer Oral P2Y12 Inhibitors (Prasugrel or Ticagrelor) to Clopidogrel in Patients With Non ST-Elevation Acute Coronary Syndrome
    Bavishi, Chirag
    Panwar, Sadik
    Messerli, Franz H.
    Bangalore, Sripal
    AMERICAN JOURNAL OF CARDIOLOGY, 2015, 116 (05): : 809 - 817
  • [47] Adherence to P2Y12 inhibitors in acute coronary syndrome after a percutaneous coronary intervention: what can we improve?
    Han, Yaling
    Li, Yang
    EUROPEAN HEART JOURNAL, 2022, 43 (24) : 2314 - 2316
  • [48] P2Y12 inhibitors for the treatment of acute coronary syndrome patients undergoing percutaneous coronary intervention: current understanding and outcomes
    Alexopoulos, Dimitrios
    Varlamos, Charalampos
    Mpahara, Aikaterini
    Lianos, Ioannis
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2019, 17 (10) : 717 - 727
  • [49] Mismatch between the European and American guidelines on oral antiplatelet P2Y12 inhibitors after acute coronary syndromes
    Serebruany, V. L.
    EUROPEAN HEART JOURNAL, 2013, 34 : 470 - 471
  • [50] Characteristics of new P2Y12 inhibitors: selection of P2Y12 inhibitors in clinical practice
    Golino, Paolo
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2013, 14 : S22 - S30
12345